Market Research

Global Nucleic Acids for Molecular Diagnosis Industry Growth and Trends Forecast to 2031

Best Price Guarantee Length Publisher Published Date SKU
from $3,450 104 Pages APO Research, Inc. February, 2025 APRC19603923
Best Price Guarantee
Price from $3,450
Length 104 Pages
Publisher APO Research, Inc.
Published Date February, 2025
SKU APRC19603923

Summary

According to APO Research, The global Nucleic Acids for Molecular Diagnosis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Nucleic Acids for Molecular Diagnosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Nucleic Acids for Molecular Diagnosis include Agilent Technologies, Inc., Aji Bio-Pharma, Bio-synthesis Inc., Danaher Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Kaneka Eurogentec S.A., L.G.C Biosearch Technologies and Merck KGaA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nucleic Acids for Molecular Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acids for Molecular Diagnosis.

The Nucleic Acids for Molecular Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acids for Molecular Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nucleic Acids for Molecular Diagnosis Segment by Company

Agilent Technologies, Inc.
Aji Bio-Pharma
Bio-synthesis Inc.
Danaher Corporation
Eurofins Scientific SE
Integrated DNA Technologies
Kaneka Eurogentec S.A.
L.G.C Biosearch Technologies
Merck KGaA
metabion
QIAGEN
Thermo Fisher Scientific Inc.
Hongene
Synthgene

Nucleic Acids for Molecular Diagnosis Services Segment by Type

DNA Series
RNA Series

Nucleic Acids for Molecular Diagnosis Segment by Application

Early Cancer Screening
Genetic Diseases
Blood Screening
Genome Sequencing
Infectious Diseases
Other

Nucleic Acids for Molecular Diagnosis Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acids for Molecular Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acids for Molecular Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acids for Molecular Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nucleic Acids for Molecular Diagnosis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2020-2031)
1.4.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2020-2025)
1.4.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2026-2031)
1.5 Key Regions Nucleic Acids for Molecular Diagnosis Market Size (2020-2031)
1.5.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.4 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2020-2031)
2 Nucleic Acids for Molecular Diagnosis Market by Type
2.1 Type Introduction
2.1.1 DNA Series
2.1.2 RNA Series
2.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Type
2.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Type (2020-2031)
2.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Type (2020-2025)
2.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Type (2026-2031)
2.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
2.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025)
3 Nucleic Acids for Molecular Diagnosis Market by Application
3.1 Type Introduction
3.1.1 Early Cancer Screening
3.1.2 Genetic Diseases
3.1.3 Blood Screening
3.1.4 Genome Sequencing
3.1.5 Infectious Diseases
3.1.6 Other
3.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Application
3.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size Overview by Application (2020-2031)
3.2.2 Global Nucleic Acids for Molecular Diagnosis Historic Market Size Review by Application (2020-2025)
3.2.3 Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Application (2026-2031)
3.3 Global Nucleic Acids for Molecular Diagnosis Market Size by Regions
3.3.1 North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.4 South America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Nucleic Acids for Molecular Diagnosis Industry Trends
4.2 Nucleic Acids for Molecular Diagnosis Industry Drivers
4.3 Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges
4.4 Nucleic Acids for Molecular Diagnosis Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Nucleic Acids for Molecular Diagnosis Revenue (2020-2025)
5.2 Global Nucleic Acids for Molecular Diagnosis Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Nucleic Acids for Molecular Diagnosis Key Company Headquarters & Area Served
5.4 Global Nucleic Acids for Molecular Diagnosis Company, Product Type & Application
5.5 Global Nucleic Acids for Molecular Diagnosis Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Nucleic Acids for Molecular Diagnosis Market CR5 and HHI
5.6.2 Global Top 5 and 10 Nucleic Acids for Molecular Diagnosis Players Market Share by Revenue in 2024
5.6.3 2024 Nucleic Acids for Molecular Diagnosis Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Agilent Technologies, Inc.
6.1.1 Agilent Technologies, Inc. Comapny Information
6.1.2 Agilent Technologies, Inc. Business Overview
6.1.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.1.5 Agilent Technologies, Inc. Recent Developments
6.2 Aji Bio-Pharma
6.2.1 Aji Bio-Pharma Comapny Information
6.2.2 Aji Bio-Pharma Business Overview
6.2.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
6.2.5 Aji Bio-Pharma Recent Developments
6.3 Bio-synthesis Inc.
6.3.1 Bio-synthesis Inc. Comapny Information
6.3.2 Bio-synthesis Inc. Business Overview
6.3.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.3.5 Bio-synthesis Inc. Recent Developments
6.4 Danaher Corporation
6.4.1 Danaher Corporation Comapny Information
6.4.2 Danaher Corporation Business Overview
6.4.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
6.4.5 Danaher Corporation Recent Developments
6.5 Eurofins Scientific SE
6.5.1 Eurofins Scientific SE Comapny Information
6.5.2 Eurofins Scientific SE Business Overview
6.5.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
6.5.5 Eurofins Scientific SE Recent Developments
6.6 Integrated DNA Technologies
6.6.1 Integrated DNA Technologies Comapny Information
6.6.2 Integrated DNA Technologies Business Overview
6.6.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
6.6.5 Integrated DNA Technologies Recent Developments
6.7 Kaneka Eurogentec S.A.
6.7.1 Kaneka Eurogentec S.A. Comapny Information
6.7.2 Kaneka Eurogentec S.A. Business Overview
6.7.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.7.5 Kaneka Eurogentec S.A. Recent Developments
6.8 L.G.C Biosearch Technologies
6.8.1 L.G.C Biosearch Technologies Comapny Information
6.8.2 L.G.C Biosearch Technologies Business Overview
6.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
6.8.5 L.G.C Biosearch Technologies Recent Developments
6.9 Merck KGaA
6.9.1 Merck KGaA Comapny Information
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
6.9.5 Merck KGaA Recent Developments
6.10 metabion
6.10.1 metabion Comapny Information
6.10.2 metabion Business Overview
6.10.3 metabion Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
6.10.5 metabion Recent Developments
6.11 QIAGEN
6.11.1 QIAGEN Comapny Information
6.11.2 QIAGEN Business Overview
6.11.3 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
6.11.5 QIAGEN Recent Developments
6.12 Thermo Fisher Scientific Inc.
6.12.1 Thermo Fisher Scientific Inc. Comapny Information
6.12.2 Thermo Fisher Scientific Inc. Business Overview
6.12.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
6.12.5 Thermo Fisher Scientific Inc. Recent Developments
6.13 Hongene
6.13.1 Hongene Comapny Information
6.13.2 Hongene Business Overview
6.13.3 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
6.13.5 Hongene Recent Developments
6.14 Synthgene
6.14.1 Synthgene Comapny Information
6.14.2 Synthgene Business Overview
6.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
6.14.5 Synthgene Recent Developments
7 North America
7.1 North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
7.3 North America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
8.3 Europe Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
9.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
10.3 South America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025)
11.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
List of Tables
Table 1. Global Nucleic Acids for Molecular Diagnosis Market Size (US$ Million) Comparison by Region: 2020 VS 2024 VS 2031
Table 2. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 3. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2020-2025)
Table 4. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 5. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2026-2031)
Table 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 7. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 8. Global Nucleic Acids for Molecular Diagnosis Market Size Share by Type (2020-2025)
Table 9. Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Type (2026-2031) & (US$ Million)
Table 10. Global Nucleic Acids for Molecular Diagnosis Market Size Share Forecasted by Type (2026-2031)
Table 11. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025) & (US$ Million)
Table 12. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2026-2031) & (US$ Million)
Table 13. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025) & (US$ Million)
Table 14. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2026-2031) & (US$ Million)
Table 15. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025) & (US$ Million)
Table 16. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2026-2031) & (US$ Million)
Table 17. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025) & (US$ Million)
Table 18. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2026-2031) & (US$ Million)
Table 19. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2020-2025) & (US$ Million)
Table 20. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Type (2026-2031) & (US$ Million)
Table 21. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 22. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 23. Global Nucleic Acids for Molecular Diagnosis Market Size Share by Application (2020-2025)
Table 24. Global Nucleic Acids for Molecular Diagnosis Market Size Forecasted by Application (2026-2031) & (US$ Million)
Table 25. Global Nucleic Acids for Molecular Diagnosis Market Size Share Forecasted by Application (2026-2031)
Table 26. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025) & (US$ Million)
Table 27. North America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2026-2031) & (US$ Million)
Table 28. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025) & (US$ Million)
Table 29. Europe Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2026-2031) & (US$ Million)
Table 30. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025) & (US$ Million)
Table 31. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2026-2031) & (US$ Million)
Table 32. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025) & (US$ Million)
Table 33. Latin America Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2026-2031) & (US$ Million)
Table 34. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2020-2025) & (US$ Million)
Table 35. Middle East and Africa Nucleic Acids for Molecular Diagnosis Market Size Breakdown by Application (2026-2031) & (US$ Million)
Table 36. Nucleic Acids for Molecular Diagnosis Industry Trends
Table 37. Nucleic Acids for Molecular Diagnosis Industry Drivers
Table 38. Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges
Table 39. Nucleic Acids for Molecular Diagnosis Industry Restraints
Table 40. Global Nucleic Acids for Molecular Diagnosis Revenue by Company (US$ Million) & (2020-2025)
Table 41. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Company (2020-2025)
Table 42. Global Nucleic Acids for Molecular Diagnosis Industry Company Ranking, 2023 VS 2024 VS 2025
Table 43. Global Nucleic Acids for Molecular Diagnosis Key Company Headquarters & Area Served
Table 44. Global Nucleic Acids for Molecular Diagnosis Company, Product Type & Application
Table 45. Global Nucleic Acids for Molecular Diagnosis Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Nucleic Acids for Molecular Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 48. Agilent Technologies, Inc. Business Overview
Table 49. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 50. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 51. Agilent Technologies, Inc. Recent Development
Table 52. Aji Bio-Pharma Company Information
Table 53. Aji Bio-Pharma Business Overview
Table 54. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 55. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 56. Aji Bio-Pharma Recent Development
Table 57. Bio-synthesis Inc. Company Information
Table 58. Bio-synthesis Inc. Business Overview
Table 59. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 60. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 61. Bio-synthesis Inc. Recent Development
Table 62. Danaher Corporation Company Information
Table 63. Danaher Corporation Business Overview
Table 64. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 65. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 66. Danaher Corporation Recent Development
Table 67. Eurofins Scientific SE Company Information
Table 68. Eurofins Scientific SE Business Overview
Table 69. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 70. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 71. Eurofins Scientific SE Recent Development
Table 72. Integrated DNA Technologies Company Information
Table 73. Integrated DNA Technologies Business Overview
Table 74. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 75. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 76. Integrated DNA Technologies Recent Development
Table 77. Kaneka Eurogentec S.A. Company Information
Table 78. Kaneka Eurogentec S.A. Business Overview
Table 79. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 80. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 81. Kaneka Eurogentec S.A. Recent Development
Table 82. L.G.C Biosearch Technologies Company Information
Table 83. L.G.C Biosearch Technologies Business Overview
Table 84. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 85. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 86. L.G.C Biosearch Technologies Recent Development
Table 87. Merck KGaA Company Information
Table 88. Merck KGaA Business Overview
Table 89. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 90. Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 91. Merck KGaA Recent Development
Table 92. metabion Company Information
Table 93. metabion Business Overview
Table 94. metabion Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 95. metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 96. metabion Recent Development
Table 97. QIAGEN Company Information
Table 98. QIAGEN Business Overview
Table 99. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 100. QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 101. QIAGEN Recent Development
Table 102. Thermo Fisher Scientific Inc. Company Information
Table 103. Thermo Fisher Scientific Inc. Business Overview
Table 104. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 105. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 106. Thermo Fisher Scientific Inc. Recent Development
Table 107. Hongene Company Information
Table 108. Hongene Business Overview
Table 109. Hongene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 110. Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 111. Hongene Recent Development
Table 112. Synthgene Company Information
Table 113. Synthgene Business Overview
Table 114. Synthgene Nucleic Acids for Molecular Diagnosis Revenue (US$ Million), Global Share (%) and Gross Margin (2020-2025)
Table 115. Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
Table 116. Synthgene Recent Development
Table 117. North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 118. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 119. North America Nucleic Acids for Molecular Diagnosis Market Share by Country (2020-2025)
Table 120. North America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031) & (US$ Million)
Table 121. North America Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2026-2031)
Table 122. Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 123. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 124. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country (2020-2025)
Table 125. Europe Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031) & (US$ Million)
Table 126. Europe Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2026-2031)
Table 127. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 128. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 129. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Country (2020-2025)
Table 130. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031) & (US$ Million)
Table 131. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2026-2031)
Table 132. Latin America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 133. Latin America Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 134. Latin America Nucleic Acids for Molecular Diagnosis Market Share by Country (2020-2025)
Table 135. Latin America Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031) & (US$ Million)
Table 136. Latin America Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2026-2031)
Table 137. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 138. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 139. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share by Country (2020-2025)
Table 140. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Forecast by Country (2026-2031) & (US$ Million)
Table 141. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share Forecast by Country (2026-2031)
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources

$3,450
$5,175
$6,900

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings